Drug Profile
Zagociguat - Cyclerion Therapeutics
Alternative Names: CY-6463; IW-6463Latest Information Update: 27 Oct 2023
Price :
$50
*
At a glance
- Originator Ironwood Pharmaceuticals
- Developer Cyclerion Therapeutics
- Class Antidementias; Antipsychotics; Nootropics; Small molecules
- Mechanism of Action Soluble guanylyl cyclase agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Alzheimer's disease; Mitochondrial disorders
- Phase I Schizophrenia
- No development reported Dementia